Home Cart Sign in  
Chemical Structure| 1642581-63-2 Chemical Structure| 1642581-63-2

Structure of Glumetinib
CAS No.: 1642581-63-2

Chemical Structure| 1642581-63-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Glumetinib is a novel, potent and highly selective inhibitor of c-Met.

Synonyms: Gumarontinib; SCC244

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Glumetinib

CAS No. :1642581-63-2
Formula : C21H17N9O2S
M.W : 459.48
SMILES Code : O=S(N1N=CC2=NC=C(C=C21)C3=CN(N=C3)C)(C4=CN=C5C=CC(C6=CN(N=C6)C)=CN54)=O
Synonyms :
Gumarontinib; SCC244
MDL No. :MFCD31693844
InChI Key :RYBLECYFLJXEJX-UHFFFAOYSA-N
Pubchem ID :117797905

Safety of Glumetinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Glumetinib

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04270591 C-Met Exon 14 Mutation PHASE1|PHASE2 RECRUITING 2023-12-30 Norton Cancer Institute, Louis... More >>ville, Kentucky, 40233, United States|The Oncology Institute of Hope & Innovation, Louisville, Kentucky, 40233, United States|Anhui Province Hospital, Hefei, Anhui, 230000, China|The Chest Hospital of Anhui Province, Hefei, Anhui, 230000, China|Beijing Cancer Hospital, Beijing, Beijing, 100000, China|Beijing Cancer Hospita, Beijing, Beijing, 100000, China|Peking Union Medical College Hospital, Beijing, Beijing, 100000, China|Union Medical College Hospital Affiliated to Fujian Medical University, Fuzhou, Fujian, 350000, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510000, China|Cancer Hospital Affiliated to Guangxi Medical University, Nanning, Guangxi, 530000, China|Hainan Cancer Hospital, Haikou, Hainan, 570000, China|Cancer Hospital Affiliated to Harbin Medical University, Ha'erbin, Heilongjiang, 150000, China|Henan Province Cancer Hospital, Zhengzhou, Henan, 450000, China|Hubei Cancer Hospital, Wuhan, Hubei, 430000, China|Wuhan Union Hospital, Wuhan, Hubei, 430000, China|Xiangya Hospital Central South University, Changsha, Hunan, 410000, China|Jiangsu Cancer Hospital, Nanjing, Jiangsu, 210000, China|Jiangsu Province People's Hospital, Nanjing, Jiangsu, 210000, China|The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330000, China|First Hospital of Jilin University, Changchun, Jilin, 130000, China|Liaoning Cancer Hospital, Shenyang, Liaoning, 110000, China|Affiliated Hospital of Hebei University, Baoding, Shandong, 071000, China|Shandong University Qilu Hospital, Jinan, Shandong, 250000, China|Changhai Hospital, Shanghai, Shanghai, 200000, China|Fudan university Shanghai cancer center, Shanghai, Shanghai, 200000, China|The Chest Hospital of Shanghai, Shanghai, Shanghai, 200000, China|West China Hospital of Sichuan University, Chengdu, Sichuan, 610000, China|Tianjin Cancer Hospital, Tianjin, Tianjin, 300000, China|Tianjin Medical University General Hospital, Tianjin, Tianjin, 300000, China|The First Affiliated Hospital,College of of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310000, China|Zhejiang Province Cancer Hospital, Hangzhou, Zhejiang, 310000, China|Hunan Province Cancer Hospital, Changsha, 410000, China|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China|Ehime University Hospital, Ehime, Japan|Kyushu University Hospital, Fukuoka, Japan|Kanagawa Cancer Center, Kanagawa, Japan|Niigata Cancer Center Hospital, Niigata, Japan|Kindai University Hospital, Osaka, Japan|Osaka International Cancer Institute, Osaka, Japan|Hokkaido University Hospital, Sapporo, Japan|Shizuoka Cancer Center, Shizuoka, Japan|National Cancer Center Hospital East, Tokyo, Japan|National Cancer center, Tokyo, Japan|Tottori University Hospital, Tottori, Japan Less <<
NCT04338243 Negative T790M Mutation and Me... More >>t Amplification Less << PHASE1|PHASE2 UNKNOWN 2020-12-31 Beijing Cancer Hospital, Beiji... More >>ng, Beijing, 100000, China Less <<
NCT05507294 Healthy Volunteers PHASE1 COMPLETED 2021-09-30 Zhongshan Hositpal, Shanghai, ... More >>Shanghai, 200020, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.18mL

0.44mL

0.22mL

10.88mL

2.18mL

1.09mL

21.76mL

4.35mL

2.18mL

References

 

Historical Records

Categories